205 related articles for article (PubMed ID: 31736766)
1. Ursolic Acid Improves Intestinal Damage and Bacterial Dysbiosis in Liver Fibrosis Mice.
Wan SZ; Liu C; Huang CK; Luo FY; Zhu X
Front Pharmacol; 2019; 10():1321. PubMed ID: 31736766
[TBL] [Abstract][Full Text] [Related]
2. Ursolic acid reverses liver fibrosis by inhibiting interactive NOX4/ROS and RhoA/ROCK1 signalling pathways.
Wan S; Luo F; Huang C; Liu C; Luo Q; Zhu X
Aging (Albany NY); 2020 Jun; 12(11):10614-10632. PubMed ID: 32496208
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid improves the bacterial community mapping of the intestinal tract in liver fibrosis mice.
Wan S; Huang C; Wang A; Zhu X
PeerJ; 2020; 8():e9050. PubMed ID: 32355580
[TBL] [Abstract][Full Text] [Related]
4. Protective Effect of Ursolic Acid on the Intestinal Mucosal Barrier in a Rat Model of Liver Fibrosis.
Zhang W; Gan D; Jian J; Huang C; Luo F; Wan S; Jiang M; Wan Y; Wang A; Li B; Zhu X
Front Physiol; 2019; 10():956. PubMed ID: 31417419
[TBL] [Abstract][Full Text] [Related]
5. Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis.
Nie Y; Liu Q; Zhang W; Wan Y; Huang C; Zhu X
Gut Microbes; 2021; 13(1):1972746. PubMed ID: 34530693
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbial Dysbiosis Is Associated With Profibrotic Factors in Liver Fibrosis Mice.
Wan S; Nie Y; Zhang Y; Huang C; Zhu X
Front Cell Infect Microbiol; 2020; 10():18. PubMed ID: 32083022
[No Abstract] [Full Text] [Related]
7. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
[TBL] [Abstract][Full Text] [Related]
8. Dietary Ursolic Acid Prevents Alcohol-Induced Liver Injury via Gut-Liver Axis Homeostasis Modulation: The Key Role of Microbiome Manipulation.
Yan X; Ren X; Liu X; Wang Y; Ma J; Song R; Wang X; Dong Y; Fan Q; Wei J; Yu A; She G
J Agric Food Chem; 2021 Jun; 69(25):7074-7083. PubMed ID: 34152776
[TBL] [Abstract][Full Text] [Related]
9. Rosmarinic acid alleviates intestinal inflammatory damage and inhibits endoplasmic reticulum stress and smooth muscle contraction abnormalities in intestinal tissues by regulating gut microbiota.
Li K; Wu J; Xu S; Li X; Zhang Y; Gao XJ
Microbiol Spectr; 2023 Aug; 11(5):e0191423. PubMed ID: 37594285
[TBL] [Abstract][Full Text] [Related]
10. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
De Minicis S; Rychlicki C; Agostinelli L; Saccomanno S; Candelaresi C; Trozzi L; Mingarelli E; Facinelli B; Magi G; Palmieri C; Marzioni M; Benedetti A; Svegliati-Baroni G
Hepatology; 2014 May; 59(5):1738-49. PubMed ID: 23959503
[TBL] [Abstract][Full Text] [Related]
11. Ursolic acid ameliorates carbon tetrachloride-induced oxidative DNA damage and inflammation in mouse kidney by inhibiting the STAT3 and NF-κB activities.
Ma JQ; Ding J; Xiao ZH; Liu CM
Int Immunopharmacol; 2014 Aug; 21(2):389-95. PubMed ID: 24880019
[TBL] [Abstract][Full Text] [Related]
12. Xia-Yu-Xue Decoction Inhibits Intestinal Epithelial Cell Apoptosis in CCl4-Induced Liver Fibrosis.
Ma W; Tao L; Zhang W; Zhu Y; Xue D; Zhang J; Liu C
Cell Physiol Biochem; 2017; 44(1):333-344. PubMed ID: 29132134
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid protects mouse liver against CCl4-induced oxidative stress and inflammation by the MAPK/NF-κB pathway.
Ma JQ; Ding J; Zhang L; Liu CM
Environ Toxicol Pharmacol; 2014 May; 37(3):975-83. PubMed ID: 24727148
[TBL] [Abstract][Full Text] [Related]
14. Symbiotic formulation in experimentally induced liver fibrosis in rats: intestinal microbiota as a key point to treat liver damage?
D'Argenio G; Cariello R; Tuccillo C; Mazzone G; Federico A; Funaro A; De Magistris L; Grossi E; Callegari ML; Chirico M; Caporaso N; Romano M; Morelli L; Loguercio C
Liver Int; 2013 May; 33(5):687-97. PubMed ID: 23448378
[TBL] [Abstract][Full Text] [Related]
15. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model.
Kanwal S; Joseph TP; Owusu L; Xiaomeng R; Meiqi L; Yi X
Nutrients; 2018 Jul; 10(8):. PubMed ID: 30065236
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid inhibits epithelial-mesenchymal transition in vitro and in vivo.
Xu CG; Zhu XL; Wang W; Zhou XJ
Pharm Biol; 2019 Dec; 57(1):169-175. PubMed ID: 30905239
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of ursolic acid in an experimental model of liver fibrosis through Nrf2/ARE pathway.
Ma JQ; Ding J; Zhang L; Liu CM
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):188-97. PubMed ID: 25459994
[TBL] [Abstract][Full Text] [Related]
19. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
[TBL] [Abstract][Full Text] [Related]
20. Modification effects of SanWei GanJiang Powder on liver and intestinal damage through reversing bile acid homeostasis.
Li N; Wang B; Wu Y; Luo X; Chen Z; Sang C; Xiong T
Biomed Pharmacother; 2019 Aug; 116():109044. PubMed ID: 31174088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
